General Information
Company Name
CellGenTech, Inc.
Head Office
Chiba-dai Inohana Innovation Plaza #208, 1-8-15, Inohana, Chuo-ku,
Chiba-city, Chiba 260-0856 Japan Map
Contact:info-cgt@cellgentech.com
Tokyo Office
Nihonbashi Life Science Building 7, 8th Floor, 1-9-10 Nihonbashi-Horidomecho, Chuo-ku,
Tokyo 103-0012 Japan Map
Tel:+81-3-6661-1824
Management Members
Joined Eisai Co., Ltd. in 1981, and was in charge of product planning for pharmaceutical business. Was involved in postmarketing surveilance and clinical developments. |
Joined AnGes MG, Inc. in 2001, and was engaged in debvelopments of nucleic acid drugs and gene therapy in charge of clinical developments and business planning. |
Founded CellGenTech, Inc. in 2003, and assumed CEO & President. |
Joined Asahi Glass Co., Ltd. in 1987 |
Joined the Investment Banking Division of Bank of America in 2000. |
Took part in the establishment of Watervein Partners in 2002, and became a Venture Partners of the Company (He is still in tenure of this position at present.) |
Joined CellGenTech, Inc. and became a Director. |
Joined ZACROS Co., LTD. as Deputy Division Manager, Medical Solutions Specialist, Regenerative Medicine (present post) in 2024 |
Joined CellGenTech, Inc. as a Director in 2024. |
Joined Nissui Pharmaceutical Co., LTD. as Executive Officers (present post) in 2022 |
Joined CellGenTech, Inc. as a Director in 2024. |
Joined Yamanouchi Pharmaceutical Co., Ltd. in 1984, and was engaged in new drug discovery, Corporate Planning and Intellectual Property. |
Joined Seikagaku Corporation in 2007 |
Joined API Corporation in 2013 |
Joined CellGenTech, Inc. in 2018. |
Joined Mitsui Knowledge Industry Co., Ltd. in 1975, and was engaged in system developments for financial field and bioscience field. |
Joined Novus Gene as Director in 2001 |
Worked as facilitator at Incubation institutes for Venture Business at Chiba University. Joined CellGenTech, Inc. in 2018. |
Joined Eisai Co., Ltd. in 1981 |
Joined Sunplanet Co., Ltd. as CEO (present post) in 2014 |
Joined CellGenTech, Inc. in 2023. |